Chan Wing-lok, Lam Ka-on, Siu Wai-kwan, Yuen Kwok-keung
Department of Clinical Oncology, Queen Mary Hospital, 1/F Professorial Block, 102 Pokfulam Road, Pokfulam, Hong Kong.
Department of Clinical Oncology, The University of Hong Kong, Pokfulam, Hong Kong.
Support Care Cancer. 2016 Mar;24(3):1421-7. doi: 10.1007/s00520-015-3031-z. Epub 2015 Nov 25.
Palliative chemotherapy is increasingly used in cancer patients near end of life. With the development of newer anticancer agents which have less side effects and higher expected efficacy, the decision on palliative chemotherapy in patients near end of life is complex. This article illustrates how oncologist and palliative care physicians can work together effectively. This article also gives an overview about the risks of palliative chemotherapy near end of life, patients' and physicians' perspectives in choosing the aggressive treatment and describes what an oncologist should do when facing this challenging situation.
姑息性化疗在癌症终末期患者中越来越常用。随着副作用更小、预期疗效更高的新型抗癌药物的研发,对于癌症终末期患者姑息性化疗的决策变得复杂。本文阐述了肿瘤学家和姑息治疗医生如何能有效地合作。本文还概述了癌症终末期姑息性化疗的风险、患者和医生在选择积极治疗时的观点,并描述了肿瘤学家在面对这种具有挑战性的情况时应如何做。